This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Covx Technologies Ireland Limited, Pfizer Healthcare Ireland. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2023
Title: Innovations of Wei Hong Yu in Antibody Technology
Introduction
Wei Hong Yu is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. With a total of 2 patents, his work focuses on enhancing the efficacy of therapeutic antibodies.
Latest Patents
Wei Hong Yu's latest patents include groundbreaking inventions such as "Mutant antibodies and conjugation thereof." This invention relates to a polypeptide comprising 7 β-strands A, B, C, D, E, F, and G, which are sequentially connected by chains of amino acids. The structure includes a first α-helix located on the EF chain between β-strands E and F. The arrangement of these β-strands forms two distinct β-sheets, which are covalently bonded to create a first Ig domain. The EF chain is characterized by a specific amino acid sequence, enhancing its pharmaceutical applications.
Another notable patent is "Multifunctional antibody conjugates." This invention describes multifunctional antibody conjugates that include an antibody or an antigen-binding portion. The conjugates consist of a fragment of a light chain constant kappa region and a linker that connects the antibody to at least one effector moiety. This innovative approach aims to improve the therapeutic potential of antibody-based treatments.
Career Highlights
Wei Hong Yu has worked with prominent companies in the biotechnology sector, including Covx Technologies Ireland Limited and Pfizer Healthcare Ireland. His experience in these organizations has contributed to his expertise in antibody development and innovation.
Collaborations
Wei has collaborated with notable professionals in the field, including Abhijit Suresh Bhat and Olivier Alexandre Laurent. These collaborations have further enriched his research and development efforts.
Conclusion
Wei Hong Yu's contributions to antibody technology through his patents and collaborations highlight his role as a leading inventor in the biotechnology field. His innovative approaches continue to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile